Sfoglia per Rivista DIABETES/METABOLISM RESEARCH AND REVIEWS
Challenges in developing endpoints for type 1 diabetes intervention studies
2009-01-01 Cernea, S; Raz, I; Herold, Kc; Hirshberg, B; Roep, Bo; Schatz, Da; Fleming, Ga; Pozzilli, P; Little, R; Schloot, Nc; Leslielo, Rdg; Skyler, Js; Palmer, Jp
Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies
2009-01-01 Khoo, Cp; Valorani, Mg; Brittan, M; Alison, Mr; Warnes, G; Johansson, U; Hawa, M; Pozzilli, P
Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
2016-01-01 Pozzilli, P; Battelino, T; Danne, T; Hovorka, R; Jarosz-Chobot, P; Renard, E
Diabetes classification: grey zones, sound and smoke: Action LADA 1
2008-01-01 Leslie, Rdg; Kolb, H; Schloot, Nc; Buzzetti, R; Mauricio, D; De Leiva, A; Yderstraede, K; Sarti, C; Thivolet, C; Hadden, D; Ter, S; Schernthaner, G; Scherbaum, W; Williams, R; Pozzilli, P
Diabetes in chronic liver disease: from old concepts to new evidence
2006-01-01 Picardi, A; D'Avola, D; VESPASIANI GENTILUCCI, U; Galati, G; Fiori, E; Spataro, S; Afeltra, A
Diabetes on demand and novel technologies
2018-01-01 Maurizi, A; Piemonte, V; Pozzilli, P
Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension
2019-01-01 Fuso, L; Pitocco, D; Antonelli Incalzi, R
Diet can influence the ability of nicotinamide to prevent diabetes in the non-obese diabetic mouse: a preliminary study
1999-01-01 Beales, Pe; Burr, La; Webb, Gp; Mansfield, Kj; Pozzilli, P
DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19?
2020-01-01 Strollo, R; Pozzilli, P
Editors' note to Raz and Eldor's commentary "Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms". Diabetes Metab Res Rev 2012
2012-01-01 Roth, J; Pozzilli, P
Effect of diet on type 2 diabetes mellitus: a review
2014-01-01 Khazrai, Ym; Defeudis, G; Pozzilli, P
Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes
2017-01-01 Guglielmi, C; Del Toro, R; Lauria, A; Maurizi, Ar; Fallucca, S; Cappelli, A; Angeletti, S; Lachin, Jm; Pozzilli, P
Epigenetics in autoimmune diseases with focus on type 1 diabetes
2013-01-01 Dang, Mn; Buzzetti, R; Pozzilli, P
Erectile dysfunction and diabetes: A melting pot of circumstances and treatments
2022-01-01 Defeudis, G.; Mazzilli, R.; Tenuta, M.; Rossini, G.; Zamponi, V.; Olana, S.; Faggiano, A.; Pozzilli, P.; Isidori, A. M.; Gianfrilli, D.
Fast publication, a must for a journal
2018-01-01 Pozzilli, P
Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy?
2016-01-01 Maddaloni, E; D'Onofrio, L; Pozzilli, P
Gene therapy and enhancement for diabetes (and other diseases): the multiplicity of considerations
2010-01-01 Bertolaso, M; Olsson, J; Picardi, A; Rakela, J
Genetic prediction of type 1 diabetes in a poputation with tow frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study)
2004-01-01 Buzzetti, R; Galgani, A; Petrone, A; Buono, Mld; Erlich, Ha; Bugawan, Tl; Lorini, R; Meschi, F; Multari, G; Pozzilli, P; Locatelli, M; Bottazzo, G; Di Mario, U
Global status of diabetes prevention and prospects for action: A consensus statement
2018-01-01 Ibrahim, M.; Tuomilehto, J.; Aschner, P.; Beseler, L.; Cahn, A.; Eckel, R. H.; Fischl, A. H.; Guthrie, G.; Hill, J. O.; Kumwenda, M.; Leslie, R. D.; Olson, D. E.; Pozzilli, P; Weber, S. L.; Umpierrez, G. E.
Glucose control in diabetes
2004-01-01 Valeri, C; Pozzilli, P; Leslie, D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Challenges in developing endpoints for type 1 diabetes intervention studies | 1-gen-2009 | Cernea, S; Raz, I; Herold, Kc; Hirshberg, B; Roep, Bo; Schatz, Da; Fleming, Ga; Pozzilli, P; Little, R; Schloot, Nc; Leslielo, Rdg; Skyler, Js; Palmer, Jp | |
| Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies | 1-gen-2009 | Khoo, Cp; Valorani, Mg; Brittan, M; Alison, Mr; Warnes, G; Johansson, U; Hawa, M; Pozzilli, P | |
| Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics | 1-gen-2016 | Pozzilli, P; Battelino, T; Danne, T; Hovorka, R; Jarosz-Chobot, P; Renard, E | |
| Diabetes classification: grey zones, sound and smoke: Action LADA 1 | 1-gen-2008 | Leslie, Rdg; Kolb, H; Schloot, Nc; Buzzetti, R; Mauricio, D; De Leiva, A; Yderstraede, K; Sarti, C; Thivolet, C; Hadden, D; Ter, S; Schernthaner, G; Scherbaum, W; Williams, R; Pozzilli, P | |
| Diabetes in chronic liver disease: from old concepts to new evidence | 1-gen-2006 | Picardi, A; D'Avola, D; VESPASIANI GENTILUCCI, U; Galati, G; Fiori, E; Spataro, S; Afeltra, A | |
| Diabetes on demand and novel technologies | 1-gen-2018 | Maurizi, A; Piemonte, V; Pozzilli, P | |
| Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension | 1-gen-2019 | Fuso, L; Pitocco, D; Antonelli Incalzi, R | |
| Diet can influence the ability of nicotinamide to prevent diabetes in the non-obese diabetic mouse: a preliminary study | 1-gen-1999 | Beales, Pe; Burr, La; Webb, Gp; Mansfield, Kj; Pozzilli, P | |
| DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19? | 1-gen-2020 | Strollo, R; Pozzilli, P | |
| Editors' note to Raz and Eldor's commentary "Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms". Diabetes Metab Res Rev 2012 | 1-gen-2012 | Roth, J; Pozzilli, P | |
| Effect of diet on type 2 diabetes mellitus: a review | 1-gen-2014 | Khazrai, Ym; Defeudis, G; Pozzilli, P | |
| Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes | 1-gen-2017 | Guglielmi, C; Del Toro, R; Lauria, A; Maurizi, Ar; Fallucca, S; Cappelli, A; Angeletti, S; Lachin, Jm; Pozzilli, P | |
| Epigenetics in autoimmune diseases with focus on type 1 diabetes | 1-gen-2013 | Dang, Mn; Buzzetti, R; Pozzilli, P | |
| Erectile dysfunction and diabetes: A melting pot of circumstances and treatments | 1-gen-2022 | Defeudis, G.; Mazzilli, R.; Tenuta, M.; Rossini, G.; Zamponi, V.; Olana, S.; Faggiano, A.; Pozzilli, P.; Isidori, A. M.; Gianfrilli, D. | |
| Fast publication, a must for a journal | 1-gen-2018 | Pozzilli, P | |
| Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy? | 1-gen-2016 | Maddaloni, E; D'Onofrio, L; Pozzilli, P | |
| Gene therapy and enhancement for diabetes (and other diseases): the multiplicity of considerations | 1-gen-2010 | Bertolaso, M; Olsson, J; Picardi, A; Rakela, J | |
| Genetic prediction of type 1 diabetes in a poputation with tow frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study) | 1-gen-2004 | Buzzetti, R; Galgani, A; Petrone, A; Buono, Mld; Erlich, Ha; Bugawan, Tl; Lorini, R; Meschi, F; Multari, G; Pozzilli, P; Locatelli, M; Bottazzo, G; Di Mario, U | |
| Global status of diabetes prevention and prospects for action: A consensus statement | 1-gen-2018 | Ibrahim, M.; Tuomilehto, J.; Aschner, P.; Beseler, L.; Cahn, A.; Eckel, R. H.; Fischl, A. H.; Guthrie, G.; Hill, J. O.; Kumwenda, M.; Leslie, R. D.; Olson, D. E.; Pozzilli, P; Weber, S. L.; Umpierrez, G. E. | |
| Glucose control in diabetes | 1-gen-2004 | Valeri, C; Pozzilli, P; Leslie, D |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile